PSI Metrics

Summary Statistics for the PSI-2 Program

Summary of Measures of Success for Experimental Structure Determination and Modeling Leverage as Described in the Goals and Milestones Document


Distinct Structures: Structures with less than 98% sequence identity to an existing structure at the time of PDB deposition

Novel Structures: Structures with less than 30% sequence identity to an existing structure at the time of PDB deposition

Updated June 24, 2009


I.1.A Number of Novel Experimental PSI-2 Structures 1564
I.1.B Number of Distinct Experimental PSI-2 Structures with Nonredundant Sequences 2289
I.1.D Total Number of Experimental PSI-2 Structures 2566
I.1.E Numbers of Experimentally Determined Distinct Residues 511440
Numbers of Experimentally Determined Novel Residues 343592
I.2.B Number of Experimental Structures from Biomedical Theme Target Lists 787
I.2.C Number of Experimental Structures from Community Outreach Target Lists 290
I.2.J Number of Experimental Structures of Human Proteins 84
I.2.K Number of Experimental Structures of Eukaryotic Proteins 241
I.2.M Number of Experimental Structures of Membrane Proteins 28
I.2.N Number of Experimental Structures Determined at the Atomic Level using X-ray Crystallography 2336
Number of Experimental Structures Determined at the Atomic Level using NMR Methods 230

Updated April 1, 2009


I.1.C Number of BIG Domain Families for which PSI-2 provides the first Experimental Structure Representative 375
Number of MEGA Modeling Families for which PSI-2 provides the first Experimental Structure Representative 365
Number of Experimentally Determined Distinct BIG Family Structures 587
Numbers of Experimentally Determined Distinct MEGA Modeling Family Structures 466
I.1.E Numbers of Experimentally Determined Distinct BIG Family Residues 122186
Numbers of Experimentally Determined Distinct MEGA Modeling Family Residues 120073

Updated May 1, 2008


I.3.B Novel Modeling Leverage 194755